HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification

Cell Reports

Volumn 7, Issue 2, 2014, Pages 448-463

  Tenzer, Stefan ^a   Crawford, Hayley ^b,c   Pymm, Phillip ^b,c   Gifford, Robert ^d   Sreenu, VattipallyB ^b   Weimershaus, Mirjana ^e   deOliveira, Tulio ^f,g   Burgevin, Anne ^e   Gerstoft, Jan ^h   Akkad, Nadja ^a   Lunn, Daniel ⁱ   Fugger, Lars ^b,c   Bell, John ⁱ   Schild, Hansjörg ^a   vanEndert, Peter ^e   Iversen, Astrid K N ^b,c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^e CNRS   (France)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h Rigshospitalet   (Denmark)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; EPITOPE; HLA A1 ANTIGEN;

AFRICAN; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CAUCASIAN; CD8+ T LYMPHOCYTE; CELL SURFACE; DISEASE COURSE; ETHNIC GROUP; GENE FREQUENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; IMMUNOGENICITY; POPULATION RESEARCH; PRIORITY JOURNAL; T LYMPHOCYTE; ADAPTATION; AFRICA; AMINO ACID SEQUENCE; EUROPE; GENETICS; HIV INFECTIONS; IMMUNOLOGY; MOLECULAR GENETICS; POPULATION;

ADAPTATION, PHYSIOLOGICAL; AFRICA, SOUTHERN; AMINO ACID SEQUENCE; EPITOPES; EUROPE; GENE FREQUENCY; HIV INFECTIONS; HIV-1; HLA-A1 ANTIGEN; HUMANS; IMMUNE EVASION; MOLECULAR SEQUENCE DATA; POPULATION; T-LYMPHOCYTES;

EID: 84899644896     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.031     Document Type: Article

References (48)

1. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., Asher T.E., Samri A., Schnuriger A., Theodorou I., et al. Superior control of HIV-1 replication by CD8+ Tcells is reflected by their avidity, polyfunctionality, and clonal turnover. J.Exp. Med. 2007, 204:2473-2485.
2. Assane A.A., Fabricio-Silva G.M., Cardoso-Oliveira J., Mabunda N.E., Sousa A.M., Jani I.V., Ferreira O.C., Porto L.C. Human leukocyte antigen-A, -B, and -DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor-based population study. Hum. Immunol. 2010, 71:1027-1032.
3. Bhattacharya T., Daniels M., Heckerman D., Foley B., Frahm N., Kadie C., Carlson J., Yusim K., McMahon B., Gaschen B., et al. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 2007, 315:1583-1586.
4. Brumme Z.L., Brumme C.J., Carlson J., Streeck H., John M., Eichbaum Q., Block B.L., Baker B., Kadie C., Markowitz M., et al. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J.Virol. 2008, 82:9216-9227.
5. Buonaguro L., Tornesello M.L., Buonaguro F.M. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J.Virol. 2007, 81:10209-10219.
6. Cao K., Hollenbach J., Shi X., Shi W., Chopek M., Fernández-Viña M.A. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum. Immunol. 2001, 62:1009-1030.
7. Dahirel V., Shekhar K., Pereyra F., Miura T., Artyomov M., Talsania S., Allen T.M., Altfeld M., Carrington M., Irvine D.J., et al. Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc. Natl. Acad. Sci. USA 2011, 108:11530-11535.
8. Dinges W.L., Richardt J., Friedrich D., Jalbert E., Liu Y., Stevens C.E., Maenza J., Collier A.C., Geraghty D.E., Smith J., et al. Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J.Virol. 2010, 84:4461-4468.
9. Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M., et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J.Exp. Med. 2004, 199:905-915.
10. Elahi S., Dinges W.L., Lejarcegui N., Laing K.J., Collier A.C., Koelle D.M., McElrath M.J., Horton H. Protective HIV-specific CD8+ Tcells evade Treg cell suppression. Nat. Med. 2011, 17:989-995.
11. Fadda L., O'Connor G.M., Kumar S., Piechocka-Trocha A., Gardiner C.M., Carrington M., McVicar D.W., Altfeld M. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J.Virol. 2011, 85:5970-5974.
12. Faroudi M., Utzny C., Salio M., Cerundolo V., Guiraud M., Müller S., Valitutti S. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold. Proc. Natl. Acad. Sci. USA 2003, 100:14145-14150.
13. Frahm N., Yusim K., Suscovich T.J., Adams S., Sidney J., Hraber P., Hewitt H.S., Linde C.H., Kavanagh D.G., Woodberry T., et al. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 2007, 37:2419-2433.
14. Gilbert M.T., Rambaut A., Wlasiuk G., Spira T.J., Pitchenik A.E., Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc. Natl. Acad. Sci. USA 2007, 104:18566-18570.
15. Gonzalez-Galarza F.F., Christmas S., Middleton D., Jones A.R. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011, 39(Database issue):D913-D919.
16. Goulder P.J., Walker B.D. HIV and HLA class I: an evolving relationship. Immunity 2012, 37:426-440.
17. Goulder P.J., Tang Y., Pelton S.I., Walker B.D. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. J.Virol. 2000, 74:5291-5299.
18. Gubler B., Daniel S., Armandola E.A., Hammer J., Caillat-Zucman S., van Endert P.M. Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. Mol. Immunol. 1998, 35:427-433.
19. Iversen A.K., Stewart-Jones G., Learn G.H., Christie N., Sylvester-Hviid C., Armitage A.E., Kaul R., Beattie T., Lee J.K., Li Y., et al. Conflicting selective forces affect Tcell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat. Immunol. 2006, 7:179-189.
20. Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A., Koizumi H., et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458:641-645.
21. Kessler J.H., Khan S., Seifert U., Le Gall S., Chow K.M., Paschen A., Bres-Vloemans S.A., de Ru A., van Montfoort N., Franken K.L., et al. Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic Tcell epitopes. Nat. Immunol. 2011, 12:45-53.
22. Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004, 432:769-775.
23. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007, 13:46-53.
24. Kloetzel P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2001, 2:179-187.
25. Lazaro E., Godfrey S.B., Stamegna P., Ogbechie T., Kerrigan C., Zhang M., Walker B.D., Le Gall S. Differential HIV epitope processing in monocytes and CD4 Tcells affects cytotoxic T lymphocyte recognition. J.Infect. Dis. 2009, 200:236-243.
26. Lazaro E., Kadie C., Stamegna P., Zhang S.C., Gourdain P., Lai N.Y., Zhang M., Martinez S.A., Heckerman D., Le Gall S. Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape. J.Clin. Invest. 2011, 121:2480-2492.
27. Losina E., Figueroa P., Duncan J., Divi N., Wolf L.L., Hirschhorn L.R., Robertson M., Harvey K., Whorms S., Freedberg K.A., Gebre Y. HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005. Int. J. Infect. Dis. 2008, 12:132-138.
28. Marsh S.G.E., et al. The HLA FactsBook 2000, Elsevier, London.
29. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J.Virol. 2006, 80:3617-3623.
30. Matthews P.C., Prendergast A., Leslie A., Crawford H., Payne R., Rousseau C., Rolland M., Honeyborne I., Carlson J., Kadie C., et al. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J.Virol. 2008, 82:8548-8559.
31. *3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope. J.Virol. 2012, 86:12643-12654.
32. McCullough P., Nelder J.A. Generalized Linear Models 1989, Chapman & Hall, London.
33. Novitsky V., Flores-Villanueva P.O., Chigwedere P., Gaolekwe S., Bussman H., Sebetso G., Marlink R., Yunis E.J., Essex M. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum. Immunol. 2001, 62:146-156.
34. Paulsson K.M. Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery. Cell. Mol. Life Sci. 2004, 61:2446-2460.
35. Pereyra F., Jia X., McLaren P.J., Telenti A., de Bakker P.I., Walker B.D., Ripke S., Brumme C.J., Pulit S.L., Carrington M., et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557. International HIV Controllers Study.
36. Purbhoo M.A., Irvine D.J., Huppa J.B., Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 2004, 5:524-530.
37. Rambaut A., Posada D., Crandall K.A., Holmes E.C. The causes and consequences of HIV evolution. Nat. Rev. Genet. 2004, 5:52-61.
38. + T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate. PLoS Pathog. 2011, 7:e1001341.
39. Sabbaj S., Bansal A., Ritter G.D., Perkins C., Edwards B.H., Gough E., Tang J., Szinger J.J., Korber B., Wilson C.M., et al. Cross-reactive CD8+ Tcell epitopes identified in US adolescent minorities. J.Acquir. Immune Defic. Syndr. 2003, 33:426-438.
40. *27-restricted hepatitis C virus-specific CD8+ T-cell epitope. PLoS Pathog. 2012, 8:e1003042.
41. Streeck H., Lichterfeld M., Alter G., Meier A., Teigen N., Yassine-Diab B., Sidhu H.K., Little S., Kelleher A., Routy J.P., et al. Recognition of a defined region within p24 gag by CD8+ Tcells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA classI alleles. J.Virol. 2007, 81:7725-7731.
42. Tenzer S., Stoltze L., Schönfisch B., Dengjel J., Müller M., Stevanović S., Rammensee H.G., Schild H. Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility. J.Immunol. 2004, 172:1083-1091.
43. Tenzer S., Wee E., Burgevin A., Stewart-Jones G., Friis L., Lamberth K., Chang C.H., Harndahl M., Weimershaus M., Gerstoft J., et al. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat. Immunol. 2009, 10:636-646.
44. Toes R.E., Nussbaum A.K., Degermann S., Schirle M., Emmerich N.P., Kraft M., Laplace C., Zwinderman A., Dick T.P., Müller J., et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J.Exp. Med. 2001, 194:1-12.
45. van Endert P. Post-proteasomal and proteasome-independent generation of MHC class I ligands. Cell. Mol. Life Sci. 2011, 68:1553-1567.
46. *0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. USA 1997, 94:6313-6318.
47. Zarling A.L., Lee D.R. Conversion of a human immunodeficiency virus cytotoxic T lymphocyte epitope into a high affinity HLA-Cw3 ligand. Hum. Immunol. 1998, 59:472-482.
48. Zhang S.C., Martin E., Shimada M., Godfrey S.B., Fricke J., Locastro S., Lai N.Y., Liebesny P., Carlson J.M., Brumme C.J., et al. Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals. J.Immunol. 2012, 188:5924-5934.